Dermisorb Research Ltd is an early-stage research company specialising in preclinical feasibility studies for transdermal delivery systems.

We investigate transdermal administration using validated ex vivo and synthetic dermal models, with an emphasis on carrier systems and formulation-level performance.

Featured

News and Highlights

Updates

Dermisorb Research launches

Science

Rethinking the skin as a route for delivery

Transdermal absorption offers a non-invasive pathway to deliver nutrients and compounds directly into the body. At Dermisorb, we study how this route can be used to support individuals with digestive impairments—bypassing the limitations of oral delivery. Our research is focused on understanding what’s possible and how it might change access to essential compounds in the future.

Explore

Coming Soon

Request our services

We’re currently building a library of proprietary data on transdermal absorption across various carrier systems and compounds. This material will become available for licensing and integration into pre-formulation planning.

If you'd like early access, or want to be notified when our research becomes available, please indicate your interest when contacting us.

Contact us

We welcome enquiries from formulation teams, research groups, and developers interested in non-oral delivery systems. If you're exploring the feasibility of transdermal absorption or want to discuss how our research might support your work, please get in touch.

Full name

Email address

Phone number

Message

Registered Office: G4000, 124 City Road,London, EC1V 2NX